l carnitine safe dosage The effects of L-carnitine supplementation on lipid profiles in adults: A systematic review and dose-response meta-analysis Beneficial effects of l-carnitine supplementation

IGF-1 LR3 is not appropriate for patients who are pregnant or breastfeeding, have active cancer or a cancer history (because IGF-1 stimulates cell growth broadly, including potentially malignant cells), have uncontrolled diabetes or diabetic retinopathy, or are under 21

No Therapeutic Use Exemption is available for BPC-157 because no regulatory authority has approved it for any indication

Research interest may include cellular signalling, extracellular matrix research, oxidative stress models, collagen-associated pathway research and broader peptide comparison studies

10 WADA Prohibited ListWADA Prohibited List: Livagen is not specifically named